Business
Anti-inflammatory drug may shorten COVID-19 recovery time – Sydney Morning Herald
A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalised COVID-19 patients shortens their time to recovery by an additional day.

Lilly said it planned to discuss with regulators the possible emergency use of baricitinib for hospitalised COVID-19 patients.
It would be important to know how many study participants also received steroid drugs, which have been shown in other research to lower the risk of death for severely ill, hospitalised COVID-19 patients, said Dr Jesse Goodman, former US Food and Drug Administration chief scientist now at Georgetown University who had no role in the study.
Figuring out how to best use t…
-
Noosa News23 hours ago
New South Wales Blues left to pick up the pieces after fumbling a chance at State of Origin glory
-
Noosa News17 hours ago
Help to make recycling stick
-
Noosa News15 hours ago
Former Darling Downs Zoo employee sheds new light on horrific lion attack on teacher Joanne Cabban
-
Noosa News17 hours ago
Queensland Maroons’ State of Origin decider win a perfect game of Origin football